Skip to content
Review

Screening for Advanced Liver Fibrosis: Comparing Serum Indices With Elastography in a Nationally Representative U.S. Cohort.

Aug 2026 · Military Medicine · Vol 191 Supplement_1, pp. 429-434 · 0 citations
Medicine

TL;DR

Compared widely used serum fibrosis indices against vibration-controlled transient elastography measured liver stiffness in a nationally representative sample of U.S. adults, commonly used serum fibrosis indices demonstrate limited accuracy for detecting liver stiffness associated with advanced fibrosis.

View source

Similar papers

Open access Sep 2026

Diagnostic Accuracy of Serum‐Based Fibrosis Scores for Clinically Significant Liver Fibrosis in an East Asian Cohort

ABSTRACT Serum‐based fibrosis scores are widely used for noninvasive risk stratification in chronic liver disease; however, direct comparisons across liver disease etiologies remain limited, particularly in Asian populations with a high prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. This s...

Sheng-Feng Lin, Chun-Chao Chang · 0 citations
Sep 2026

Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.

BACKGROUND AND AIMS The American Association for the Study of Liver Diseases (AASLD) recommends that a decline in liver stiffness measurement (LSM) by vibration-controlled transient elastography (VCTE) can be used as a non-invasive endpoint for treatment response in metabolic dysfunction-associated steatohepatitis (MAS...

R. Loomba, Rui-Qiu Chen, You-Xin Wang et al. · 0 citations
Open access Aug 2026

Diagnostic performance of FIB-6 for identifying FibroScan-defined advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a cross-sectional diagnostic accuracy study

Metabolic dysfunction–associated steatotic liver disease (MASLD) is a major cause of chronic liver disease worldwide. Accurate non-invasive identification of advanced fibrosis is essential for risk stratification and management. The Fibrosis-6 (FIB-6) score is a recently developed serum-based index, but its performance...

Hossein Bagheri, N. Seighali, M. Gholami-Chahkand et al. · 0 citations
Review Open access Sep 2026

FibroScan as a recommended modality for diagnosis of non-alcoholic fatty liver disease at the district level: a SWOT analysis

Non-Alcoholic Fatty Liver Disease (NAFLD), increasingly known as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is the most common chronic liver condition both globally and in India. FibroScan (vibration-controlled transient elastography; VCTE) provides a non-invasive, rapid, and reproducible alterna...

Aakash Sachdeva, Surbhi Negi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.